Onyx Biotec Limited IPO

Onyx Biotec IPO: Fresh issue of 48.1 lakh shares for INR 29.34 Cr to upgrade manufacturing, enhance packaging, repay loans, and support corporate needs.

Important Details

Open Date : November 13, 2024 Close Date : November 15, 2024 Allotment Date: November 19, 2024 Listing Date: November 21, 2024

Important Details

IPO Price: INR 58-61 per share Lot Size: 2000 Shares Total Issue Size: INR 29.34 crores

Fundamental Analysis

Onyx Biotec IPO shows mixed performance: 1. Revenue declined. 2. Liabilities and assets grew. 3. Profitability, EPS, RoNW weakened. 4. Liquidity concerns,Inventory management issues. 5. Higher debt reliance.

Swipe Up to Open Demat Account

Peer Comparison

Onyx Biotec IPO Peer Comparison: 1. Onyx Biotec, Suven Pharma, and JB Chemicals are pharma companies. 2. Diverse market capitalizations. 3. Varying stock metrics and profitability ratios. 4. Unique positions within the industry.

Objective

Onyx Biotec IPO Objective: 1. Upgrade manufacturing for large-volume parentals. 2. Add high-speed packaging for injections. 3. Repay loans for financial strength.

Risks And Challenges

Onyx Biotec IPO Risks: 1. Regional risks: economic, political, environmental. 2. Quality, procurement, and compliance challenges. 3. Potential operational disruptions and financial setbacks.